Glossary

A H N T U

A

ACLF

Acute on Chronic Liver Failure

H

H2Stem

H2Stem is Promethera’s follow-on hepato-biliary stem cell product currently in pre-clinical development with different features compared to HepaStem. 

Heparesc®

Heparesc is Promethera's cell technology comprised of liver-derived mature hepatocytes (HHLivC).  Heparesc allows for the treatment of several patients with one donated liver.

HepaStem

HepaStem is Promethera's cell therapy product comprised of Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC). It displays multiple modes of action including anti-inflammatory, anti-fibrotic effects and immunomodulation.

HHALPC

Heterologous Human Adult Liver-derived Progenitor Cells

HHLivC

Heterologous Human Liver Cells

N

NASH

Non-alcoholic Steatohepatitis

NC

North Carolina

T

TTO

The tech transfer office of UCL

U

UCD

Urea Cycle Disorders

UCL

Université Catholique de Louvain  

ULB

Université Libre de Bruxelles